זמפלר 5 מקגמל תמיסה להזרקה
abbvie biopharmaceuticals ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.
זמפלר 1 מיקרוגרם
abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.
זמפלר 1 מיקרוגרם
abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות רכות - paricalcitol 1 mcg - paricalcitol
פאריקלציטול אינובמד 5 מקגמל
inovamed ltd - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg/ml - paricalcitol
רקסטול 5 מקגמל
lapidot medical import and marketing ltd - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg / 1 ml - paricalcitol
פרקל
unipharm ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg / 1 ml - paricalcitol
זמפלר 2 מיקרוגרם
abbvie biopharmaceuticals ltd, israel - paricalcitol 2 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.
זמפלר 4 מיקרוגרם
abbvie biopharmaceuticals ltd, israel - paricalcitol 4 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.
פארסביב
amgen europe b.v. - etelcalcetide as hydrochloride - תמיסה להזרקה - etelcalcetide as hydrochloride 5 mg / 1 ml - etelcalcetide
קוראטודרם
neopharm ltd - tacalcitol 4.17 mcg/g - ointment - tacalcitol - psoriasis vulgaris. the treatment should not exceed consecutive period of 8 weeks at a maximum of 2 such periods in 12 months